Dopo l'orario di chiusura: 1.32

Veru Inc (VERU)

Veru Inc Borsa (VERU) Ultime notizie

Veru Inc (VERU)

Veru Inc Borsa (VERU) Ultime notizie

Equities Analysts Set Expectations for Veru Inc.'s Q3 2024 Earnings (NASDAQ:VERU) - Defense World

Veru Inc. (NASDAQ:VERU) Forecasted to Post Q3 2024 Earnings of ($0.05) Per Share - MarketBeat

Veru Inc. enlists top obesity expert for clinical trial - Investing.com

Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for ... - GlobeNewswire

Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight Loss

Veru (NASDAQ:VERU) Now Covered by Analysts at B. Riley - Defense World

Veru (NASDAQ:VERU) Rating Reiterated by HC Wainwright - Defense World

B. Riley Securities Initiates Coverage of Veru (VERU) with Buy Recommendation - MSN

VERU’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle

Veru Inc (VERU) financial ratios: A comprehensive overview – DWinneX - The Dwinnex

Veru (NASDAQ:VERU) Now Covered by B. Riley - MarketBeat

It makes sense and dollars to buy Veru Inc (VERU) stock – Sete News - SETE News

Veru (NASDAQ:VERU) Given "Buy" Rating at HC Wainwright - MarketBeat

Veru Inc's Banking's 100-Day Moving Average at 0.7642: Will the Stock Break Through? – Invest Chronicle - The InvestChronicle

Veru earnings missed by $0.01, revenue topped estimates - Investing.com ZA - Investing.com South Africa

VERU Stock Earnings: Veru Misses EPS, Beats Revenue for Q2 2024 - InvestorPlace

Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss ... - wallstreet:online

VERU Stock Earnings: Veru Misses EPS, Beats Revenue for Q2 2024 - InvestorPlace

Veru (NASDAQ:VERU) PT Raised to $3.00 at HC Wainwright - Defense World

Veru (NASDAQ:VERU) PT Raised to $3.00 at HC Wainwright - MarketBeat

Critical Insights From Veru Analyst Ratings: What You Need To Know

Veru (NASDAQ:VERU) PT Raised to $3.00 at HC Wainwright - MarketBeat

Veru's (NASDAQ:VERU) five-year total shareholder returns outpace the underlying earnings growth - Yahoo Lifestyle UK

Veru Inc.'s (NASDAQ:VERU) recent 20% pullback adds to one-year year losses, institutional owners may take drastic ... - Yahoo Movies Canada

Veru's (NASDAQ:VERU) five-year total shareholder returns outpace the underlying earnings growth - Yahoo Lifestyle UK

Veru (VERU) Set to Announce Quarterly Earnings on Wednesday - MarketBeat

Veru to Present at the GLP-1 Based Therapeutics Summit - Yahoo Finance

Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024

Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024 - Investing.com India

Veru Inc. (VERU) Just Flashed Golden Cross Signal: Do You Buy?

Veru enrolls first patients in Phase 2b trial of enobosarm, semaglutide - TipRanks.com - TipRanks

Baxter (BAX) to Report Q1 Earnings: What's in the Cards?

Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11

Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11 - Yahoo Finance

What Makes Veru (VERU) a New Buy Stock

What Makes Veru (VERU) a New Buy Stock - Yahoo Finance

3 Standout Penny Stocks to Watch This April - TradingView

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday

Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday - Cisco Systems (NASDAQ:CSCO) - Benzinga

Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Markets Insider

Veru Announces Date of 2024 Annual Meeting of Shareholders - Yahoo Finance

Veru Reschedules Annual Meeting of Shareholders

Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss

Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High ... - Yahoo Finance

Veru Announces Notification from Nasdaq Related to Delayed Quarterly Report on Form 10-Q

Veru Announces Notification from Nasdaq Related to Delayed Quarterly Report on Form 10-Q - Yahoo Finance

Veru Announces New Scientific Advisory Board for its Enobosarm Program for High Quality Weight Loss

Veru Announces New Scientific Advisory Board for its Enobosarm Program for High Quality Weight Loss - Yahoo Finance

Simile a VERU